Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

CD2 might be a new treatment target for patchy alopecia areata.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Tofacitinib may help treat severe hair loss, but more research is needed.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

PRP treatment may help with alopecia areata, especially in newer cases.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Monocytes might be linked to hair loss after COVID-19.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.